175 related articles for article (PubMed ID: 24351031)
21. The OXE receptor: a new therapeutic approach for asthma?
Jones CE
Trends Mol Med; 2005 Jun; 11(6):266-70. PubMed ID: 15949767
[TBL] [Abstract][Full Text] [Related]
22. Oxoeicosanoid receptor inhibition alleviates acute myocardial infarction through activation of BCAT1.
Lai Q; Yuan G; Shen L; Zhang L; Fu F; Liu Z; Zhang Y; Kou J; Liu S; Yu B; Li F
Basic Res Cardiol; 2021 Jan; 116(1):3. PubMed ID: 33484341
[TBL] [Abstract][Full Text] [Related]
23. 5-oxo-6,8,11,14-eicosatetraenoic acid is a potent stimulator of L-selectin shedding, surface expression of CD11b, actin polymerization, and calcium mobilization in human eosinophils.
Powell WS; Gravel S; Halwani F
Am J Respir Cell Mol Biol; 1999 Jan; 20(1):163-70. PubMed ID: 9870930
[TBL] [Abstract][Full Text] [Related]
24. 5-Oxo-6,8,11,14-eicosatetraenoic acid is a potent stimulator of human eosinophil migration.
Powell WS; Chung D; Gravel S
J Immunol; 1995 Apr; 154(8):4123-32. PubMed ID: 7706749
[TBL] [Abstract][Full Text] [Related]
25. Eotaxin and RANTES enhance 5-oxo-6,8,11,14-eicosatetraenoic acid-induced eosinophil chemotaxis.
Powell WS; Ahmed S; Gravel S; Rokach J
J Allergy Clin Immunol; 2001 Feb; 107(2):272-8. PubMed ID: 11174193
[TBL] [Abstract][Full Text] [Related]
26. Biochemistry, biology and chemistry of the 5-lipoxygenase product 5-oxo-ETE.
Powell WS; Rokach J
Prog Lipid Res; 2005; 44(2-3):154-83. PubMed ID: 15893379
[TBL] [Abstract][Full Text] [Related]
27. 5-oxo-6,8,11,14-eicosatetraenoic acid induces the infiltration of granulocytes into human skin.
Muro S; Hamid Q; Olivenstein R; Taha R; Rokach J; Powell WS
J Allergy Clin Immunol; 2003 Oct; 112(4):768-74. PubMed ID: 14564360
[TBL] [Abstract][Full Text] [Related]
28. Effects of 5-oxo-6,8,11,14-eicosatetraenoic acid on expression of CD11b, actin polymerization, and adherence in human neutrophils.
Powell WS; Gravel S; Halwani F; Hii CS; Huang ZH; Tan AM; Ferrante A
J Immunol; 1997 Sep; 159(6):2952-9. PubMed ID: 9300719
[TBL] [Abstract][Full Text] [Related]
29. Effects of 5-oxo-ETE on neutrophils, eosinophils, and intestinal epithelial cells.
Powell WS; Gravel S; Stamatiou P; MacLeod RJ
Adv Prostaglandin Thromboxane Leukot Res; 1995; 23():431-3. PubMed ID: 7537436
[No Abstract] [Full Text] [Related]
30. 5-Lipoxygenase products regulate basophil functions: 5-Oxo-ETE elicits migration, and leukotriene B(4) induces degranulation.
Iikura M; Suzukawa M; Yamaguchi M; Sekiya T; Komiya A; Yoshimura-Uchiyama C; Nagase H; Matsushima K; Yamamoto K; Hirai K
J Allergy Clin Immunol; 2005 Sep; 116(3):578-85. PubMed ID: 16159627
[TBL] [Abstract][Full Text] [Related]
31. Inhibitory effects of MK-886 on arachidonic acid metabolism in human phagocytes.
Ménard L; Pilote S; Naccache PH; Laviolette M; Borgeat P
Br J Pharmacol; 1990 May; 100(1):15-20. PubMed ID: 2164857
[TBL] [Abstract][Full Text] [Related]
32. 5-Oxo-ETE receptor antagonists.
Gore V; Patel P; Chang CT; Sivendran S; Kang N; Ouedraogo YP; Gravel S; Powell WS; Rokach J
J Med Chem; 2013 May; 56(9):3725-32. PubMed ID: 23581530
[TBL] [Abstract][Full Text] [Related]
33. TG1019/OXE, a Galpha(i/o)-protein-coupled receptor, mediates 5-oxo-eicosatetraenoic acid-induced chemotaxis.
Hosoi T; Sugikawa E; Chikada A; Koguchi Y; Ohnuki T
Biochem Biophys Res Commun; 2005 Sep; 334(4):987-95. PubMed ID: 16039985
[TBL] [Abstract][Full Text] [Related]
34. 5-oxo-ETE activates migration of H295R adrenocortical cells via MAPK and PKC pathways.
Neuman I; Cooke M; Lemiña NA; Kazanietz MG; Cornejo Maciel F
Prostaglandins Other Lipid Mediat; 2019 Oct; 144():106346. PubMed ID: 31301403
[TBL] [Abstract][Full Text] [Related]
35. Formation of a 5-oxo metabolite of 5,8,11,14,17-eicosapentaenoic acid and its effects on human neutrophils and eosinophils.
Powell WS; Gravel S; Gravelle F
J Lipid Res; 1995 Dec; 36(12):2590-8. PubMed ID: 8847485
[TBL] [Abstract][Full Text] [Related]
36. Stimulation of human neutrophils by 5-oxo-6,8,11,14-eicosatetraenoic acid by a mechanism independent of the leukotriene B4 receptor.
Powell WS; Gravel S; MacLeod RJ; Mills E; Hashefi M
J Biol Chem; 1993 May; 268(13):9280-6. PubMed ID: 8387490
[TBL] [Abstract][Full Text] [Related]
37. Montelukast regulates eosinophil protease activity through a leukotriene-independent mechanism.
Langlois A; Ferland C; Tremblay GM; Laviolette M
J Allergy Clin Immunol; 2006 Jul; 118(1):113-9. PubMed ID: 16815146
[TBL] [Abstract][Full Text] [Related]
38. Oxidative stress stimulates the synthesis of the eosinophil chemoattractant 5-oxo-6,8,11,14-eicosatetraenoic acid by inflammatory cells.
Erlemann KR; Rokach J; Powell WS
J Biol Chem; 2004 Sep; 279(39):40376-84. PubMed ID: 15234979
[TBL] [Abstract][Full Text] [Related]
39. 5-oxo-6,8,11,14-eicosatetraenoic acid stimulates the release of the eosinophil survival factor granulocyte/macrophage colony-stimulating factor from monocytes.
Stamatiou PB; Chan CC; Monneret G; Ethier D; Rokach J; Powell WS
J Biol Chem; 2004 Jul; 279(27):28159-64. PubMed ID: 15136573
[TBL] [Abstract][Full Text] [Related]
40. Hierarchy of eosinophil chemoattractants: role of p38 mitogen-activated protein kinase.
Schratl P; Sturm EM; Royer JF; Sturm GJ; Lippe IT; Peskar BA; Heinemann A
Eur J Immunol; 2006 Sep; 36(9):2401-9. PubMed ID: 16906532
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
